Product
2-deoxyglucose
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate CancerStatus: Terminated, Estimated PCD: 2011-03-01